“The solid [performance] confirms that the economy has continued to recover from its pandemic-induced decline, “wrote Stefan Angrick, senior economist at Oxford Economics, in a research note.
“However, high-frequency data shows that momentum started to decline in December, amid an improvement in Covid-19 cases.”
Angrick said he hoped the measures “will delay, but not hinder, the recovery in 2021, especially as it seems likely an early lifting of restrictions”.
Japan also just granted its first approval for a coronavirus vaccine, giving the green light for the injection of Pfizer-BioNTech. Sunday’s news further raised hopes that the recovery could accelerate.
“At this stage, Japan’s prospects look more favorable and the negative risks are starting to disappear. Not only have local cases of the third wave surpassed their peak, but the approval of the Pfizer vaccine is a significant development that will allow the inoculation boost to start later this week, “said Shahana Mukherjee, economist at Moody’s Analytics.
“We maintain a cautiously optimistic view of Japan’s recovery in 2021, as long as the vaccination campaign goes on without too many interruptions,” she told CNN Business.
Japan is not the only country with better GDP data. On Monday, Thailand and Singapore released new solid numbers, which helped boost investor confidence, according to Jeffrey Halley, senior Asia-Pacific market analyst at OANDA.
“The underlying image is that of a nascent recovery in … Asia [outside of China], “Halley wrote to customers. “The upbeat tone is likely to continue in Europe, unless we have some negative surprises in the headlines.”
The FTSE 100 gained 1.4% at the start of negotiations in London. Germany’s DAX increased by 0.4% and France’s CAC 40 increased by 1.1%.
– CNN’s Junko Ogura in Tokyo contributed to this report.